With findings from the first phase of a rapid evaluation of ambient voice technology in the NHS published today, co-authors ...

Ocular Therapeutix's current wet AMD treatment is dominated by anti-VEGF drugs, with EYLEA holding a 63% global market share in 2024. Read why OCUL stock is a sell.

Discusses Positive Phase 3 PROPEL 3 Results for Infigratinib in Children With Achondroplasia February 12, 2026 8:00 ...

Currently, the price of Bitcoin is putting the patience of investors to the test as it trades close to the $69,000 mark after ...

Earlier this week, UK advertising trade body the IPA released its latest Agency Census, with yet more evidence of widespread ...

The crypto market recently faced a downward trend, yet specific assets are demonstrating resilience. Zcash is a primary ...

Thank you, and welcome to everybody joining us today. Alongside this, we're continuing to make excellent progress in R&D, ...

Ethereum (ETH) has recently been having a hard time to maintain its momentum falling beneath the support of $2,100. A huge ...

Xylem Inc. (NYSE:XYL) Q4 2025 Earnings Call Transcript February 10, 2026 Xylem Inc. misses on earnings expectations. Reported EPS is $1.37 EPS, expectations were $1.42. Operator: Good day, everyone, ...

Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today reported financial results for the fourth quarter and full year ended ...

Highguard isn't ready for prime time. It's not an awful game that's unplayable. It has extremely fun moments when you're ...

You don’t need a perfect plan to get started with AI; you need a simple 90‑day path that fits around real life and real work. This roadmap is designed for professionals who are busy, a bit overwhelmed ...